SCHEDULE: Wellington Management Adjusts ProMIS Neurosciences Stake

Wellington Management Group LLP and its affiliates have reported a change in their beneficial ownership of ProMIS Neurosciences, Inc. common stock, now holding 7.8% of the class.

Summary

• Wellington Management Group LLP, along with its affiliates Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP, have filed an amendment to their Schedule 13G.
• This filing indicates a change in their beneficial ownership of ProMIS Neurosciences, Inc. common stock.
• The reporting entities collectively beneficially own 696,378 shares, representing 7.8% of the class of securities.
• The filing is an amendment to a previous filing, with the event date requiring this statement being June 30, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as neutral to slightly negative, as it primarily reports a change in beneficial ownership percentage without new strategic information or financial performance data.

Negatives

• The filing does not provide any new financial performance data or strategic updates for ProMIS Neurosciences, Inc.
• The change in ownership percentage, while reported, does not inherently signal a positive or negative development for the company itself without further context.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors crossing certain ownership thresholds. This filing reflects ongoing portfolio management activities by Wellington Management, a significant institutional investor, in the biotechnology sector.

Stakeholder Impact

• Shareholders may note the increased stake by a major institutional investor, which could be interpreted as a sign of confidence, though the filing itself does not provide strategic insights.
• The filing does not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

ProMIS Neurosciences, Wellington Management, Beneficial Ownership, Schedule 13G, Common Stock, Investment Management